Research output per year
Research output per year
Fingerprint
Dive into the research topics where PHA - Graduate School of Pharmaceutical Sciences (department affiliation only) is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
An efficient selenium transport pathway of selenoprotein P utilizing a high-affinity ApoER2 receptor variant and being independent of selenocysteine lyase
Mizuno, A., Toyama, T., Ichikawa, A., Sakai, N., Yoshioka, Y., Nishito, Y., Toga, R., Amesaka, H., Kaneko, T., Arisawa, K., Tsutsumi, R., Mita, Y., Tanaka, S. I., Noguchi, N. & Saito, Y., 2023 Aug, In: Journal of Biological Chemistry. 299, 8, 105009.Research output: Contribution to journal › Article › peer-review
Open Access -
Chromatographic Analysis of the N-Glycan Profile on Therapeutic Antibodies Using FcγRIIIa Affinity Column Chromatography
Hiranyakorn, M., Iwamoto, S., Hoshinoo, A., Tsumura, R., Takashima, H., Yasunaga, M. & Manabe, S., 2023 May 9, In: ACS Omega. 8, 18, p. 16513-16518 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Controllable conformation and reactivity of bicyclic α-methylene cyclopentanones and their NF-κB pathway inhibitory activity
Kohyama, A., Shiuchi, A., Zhou, Y., Tanioka, M., Sugimoto, K., Sakurai, H. & Matsuya, Y., 2023 May 10, In: Organic and Biomolecular Chemistry. 21, 22, p. 4656-4660 5 p.Research output: Contribution to journal › Article › peer-review
Open Access
Press/Media
-
Tohoku University Reports Findings in Selenoproteins (An efficient selenium transport pathway of selenoprotein P utilizing a high-affinity ApoER2 receptor variant and being independent of selenocysteine lyase)
Kotoko Arisawa, Takashi Toyama, Yoshiro Saito & Takayuki Kaneko
23/7/13
1 item of Media coverage
Press/Media
-
US Patent Issued to Tohoku University on March 21 for "Adamantylmethylamine derivative and use thereof as pharmaceutical" (Japanese Inventors)
Shigeki Moriguchi & Yoshiharu Iwabuchi
23/3/22
1 item of Media coverage
Press/Media